SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-062322
Filing Date
2019-11-12
Accepted
2019-11-12 11:01:39
Documents
81
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919520d3_10q.htm 10-Q 622657
2 EXHIBIT 3.1 tm1919520d3_ex3-1.htm EX-3.1 30042
3 EXHIBIT 31.1 tm1919520d3_ex31-1.htm EX-31.1 7717
4 EXHIBIT 31.2 tm1919520d3_ex31-2.htm EX-31.2 7706
5 EXHIBIT 32.1 tm1919520d3_ex32-1.htm EX-32.1 4402
6 EXHIBIT 32.2 tm1919520d3_ex32-2.htm EX-32.2 4232
7 GRAPHIC image_003.jpg GRAPHIC 8314
8 GRAPHIC image_004.jpg GRAPHIC 15324
  Complete submission text file 0001104659-19-062322.txt   4675004

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT casi-20190930.xml EX-101.INS 1052877
10 XBRL TAXONOMY EXTENSION SCHEMA casi-20190930.xsd EX-101.SCH 52807
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20190930_cal.xml EX-101.CAL 52990
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20190930_def.xml EX-101.DEF 140160
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20190930_lab.xml EX-101.LAB 365227
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20190930_pre.xml EX-101.PRE 319966
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 191207143
SIC: 2836 Biological Products, (No Diagnostic Substances)